Bloomberg ETF Analyst: The documents submitted by Grayscale still have a lot of information to be perfected
Bloomberg ETF analyst Eric Balchunas posted on the X platform saying: "Grayscale's new revised version has just been released. The document clearly stipulates that only cash is accepted, but it still does not mention a specific AP (Authorized Representative), just leaving a blank where the name should appear. The reason for this is unclear because the SEC wants to see this and they have always been quite confident in having an AP (Authorized Representative). In addition, there seems to be no information about fees in the document. This is also a major unsolved mystery."
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Morgan Stanley raises CME Group price target to $337
Chip design software leader Synopsys seeks collaboration with Chinese large model laboratories

Former BioNTech executive leads Bambusa Therapeutics (BBTX.US) in sprint to Nasdaq, "boosting" eczema drug trials
Bambusa Therapeutics Inc. has filed for an initial public offering, planning to raise funds for clinical trials of treatments for eczema and other inflammatory diseases.